Bellicum Pharmaceuticals

-$0.06 (-4.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLCM and other ETFs, options, and stocks.

About BLCM

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.

CEO
Richard A. Fair
Employees
7
Headquarters
Houston, Texas
Founded
2004

BLCM Key Statistics

Market cap
11.67M
Price-Earnings ratio
—
Dividend yield
—
Average volume
19.06K
High today
$1.50
Low today
$1.35
Open price
$1.44
Volume
31.29K
52 Week high
$4.04
52 Week low
$1.34

BLCM Earnings

-$1.37
-$0.53
$0.30
$1.14
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.25 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure